The unfulfilled promise of efficacy trials in HIV/hepatitis C co-infected patients
Journal Title: Annals of Hepatology - Year 2011, Vol 10, Issue 1
Abstract
Authors and Affiliations
Natasha Chandok, Susan John, Shariq Haider
Keywords
Related Articles
- EP ID EP78014
- DOI -
- Views 124
- Downloads 0
Genetic susceptibility to hepatoxicity due to bosentan treatment in pulmonary hypertension
Background. Hepatotoxicity is a major side effect of treatment with bosentan in patients with pulmonary hypertension (PH). Bosentan is metabolized by the cytochrome CYP2C9 and inhibits the bile salt export pump, which is...
Surgical morbidity in severely obese liver transplant recipients - A single Canadian Centre Experience
The prevalence of obesity is increasing globally, with nearly half of a billion of the world’s population now considered to be overweight or obese. Obesity and overweight patients are one of the major health issues in Ca...
Undifferentiated embryonal sarcoma of liver in an adult masquerading as complicated hydatid cyst
Benign or malignant hepatic lesions may rarely mimic inflammatory lesions on imaging. We describe a case of young adult male presenting with pain abdomen and fever of short duration. Imaging revealed large complex multis...
Actinomycotic liver abscess: A rare complication of colonic diverticular disease
We present the first case of hepatic actinomycosis requiring both medical and surgical intervention due to liver dissemination from a primary colonic abscess. A 52-year-old white male had a computerised (CT) abdominal sc...
Early allograft dysfunction after liver transplantation: an intermediate outcome measure for targeted improvements
Background. The term early allograft dysfunction (EAD) identifies liver transplant (LT) allografts with initial poor function and portends poor allograft and patient survival. Aims of this study are to use EAD as an inte...